Can a simple dilator boost sexual health after cancer treatment?
NCT ID NCT07547267
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether using a vaginal dilator for 12 weeks helps women who had brachytherapy for cervical cancer. Researchers measured sexual function, self-compassion, and quality of life in 80 participants at three time points. The goal was to see if this simple tool can ease side effects and improve well-being after treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- vaginal dilator
- What this could lead to
- If successful, this could show that using a vaginal dilator helps improve sexual function, self-compassion, and quality of life for women after cervical cancer brachytherapy.
- What could go wrong
- This is a small, completed study with 80 participants and no control group, so results may not apply to all patients. The outcomes are based on self-reported questionnaires, which can be subjective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18 years * Diagnosed with cervical cancer * Completed external radiotherapy and brachytherapy * Initiated vaginal dilator use following treatment * Able to communicate and provide informed consent * Voluntarily agreed to participate in the study Exclusion Criteria: * Presence of severe psychiatric or cognitive disorders * Diagnosis of another active malignancy * Severe comorbid conditions that may affect participation * Inability to complete questionnaires or follow the study procedures * Refusal to participate or withdrawal during the study period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brachytherapy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul Aydin University, Besyol Mahallesi, Inonu Caddesi No: 38 Kucukcekmece, Istanbul, Türkiye
Istanbul, Istanbul, 34295, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pulsed radiation extend life in metastatic cervical cancer?
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Smart speculum could bring cervical cancer screening to remote areas
- Your gut bacteria may hold the key to whether immunotherapy works
- Amazon plant put to the test against Cancer's relentless tiredness